Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 4Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1Brain Neoplasms 1

Interventions

tucatinib 1temsirolimus 1pembrolizumab 1niraparib 1lenvatinib 1atezolizumab 1Valproic Acid 1Trastuzumab 1Tissue Banks 1Sirolimus 1Immunoglobulin G 1Fulvestrant 1Doxycycline 1Disulfides 1Cetuximab 1Capecitabine 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Doxycycline × Breast × Clear all
NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡